Get the Stockscreener App
69.20
0.09%
-0.06
After Hours:
69.20
Cg Oncology Inc stock is traded at $69.20, with a volume of 967.59K.
It is down -0.09% in the last 24 hours and up +28.82% over the past month.
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
See More
Previous Close:
$69.26
Open:
$69.75
24h Volume:
967.59K
Relative Volume:
0.90
Market Cap:
$6.10B
Revenue:
$5.07M
Net Income/Loss:
$-186.75M
P/E Ratio:
-29.54
EPS:
-2.3424
Net Cash Flow:
$-160.43M
1W Performance:
-2.60%
1M Performance:
+28.82%
6M Performance:
+63.02%
1Y Performance:
+163.62%
1-Day Range:
$67.93
$70.39
1-Week Range:
$67.93
$71.88
52-Week Range:
$23.65
$77.00
Cg Oncology Inc Stock (CGON) Company Profile
Name
Cg Oncology Inc
Sector
Industry
Phone
(949) 409-3700
Address
3000 PEGASUS PARK DRIVE, DALLAS
Compare CGON vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
69.20 | 6.11B | 5.07M | -186.75M | -160.43M | -2.3424 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.93 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.50 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Initiated | Wedbush | Outperform |
| Nov-24-25 | Initiated | Truist | Buy |
| Oct-08-25 | Initiated | Guggenheim | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-10-25 | Resumed | Goldman | Buy |
| May-02-25 | Initiated | JP Morgan | Overweight |
| Apr-16-25 | Initiated | Scotiabank | Sector Perform |
| Jan-07-25 | Initiated | TD Cowen | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Sep-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Jun-28-24 | Initiated | BofA Securities | Buy |
| Feb-20-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-20-24 | Initiated | Goldman | Neutral |
| Feb-20-24 | Initiated | Morgan Stanley | Overweight |
| Feb-14-24 | Initiated | H.C. Wainwright | Buy |
View All
Cg Oncology Inc Stock (CGON) Latest News
CGONCg Oncology Inc Options - Finviz
CGON,QURE Volatility & Greeks - Finviz
CG Oncology Stock (CGON) Opinions on Director's Massive Share Purchase - Quiver Quantitative
CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director POST LEONARD E - Moomoo
Form 144 CG ONCOLOGY INC For: 1 July By Investing.com - Investing.com UK
Insider sale notice: CGON (NASDAQ: CGON) 3,928 shares via exercise - Stock Titan
Hedge Fund and Insider Trading News: Paul Singer, Warren Buffett, Ray Dalio, George Soros, Millennium Management, Point72 Asset Management, Citadel Investment Group, CG Oncology Inc (CGON), Beam Therapeutics Inc (BEAM), and More - Insider Monkey
CG Oncology stock hits all-time high at 75.79 USD - Investing.com
CG Oncology stock hits all-time high at 75.79 USD By Investing.com - Investing.com India
Monday insider trading: CG Oncology director buys $24.8M stake By Investing.com - Investing.com South Africa
Monday insider trading: CG Oncology director buys $24.8M stake - Investing.com
Top Insider Makes Massive Bet on CG Oncology’s Future - TipRanks
Form PRE 14A CG Oncology Inc For: 29 June By Investing.com - Investing.com India
Form 4 CG Oncology Inc For: 29 June By Investing.com - Investing.com Nigeria
Cg oncology director Brian Liu buys $24.8 million in shares - Investing.com UK
Cg oncology director Brian Liu buys $24.8 million in shares By Investing.com - Investing.com Nigeria
CG Oncology(CGON.US) Director Buys US$24.81 Million in Common Stock - Moomoo
CG Oncology (CGON) director-affiliated fund adds 371K shares - Stock Titan
CG Oncology | 4: Statement of changes in beneficial ownership of securities-Director Liu Brian Guan-Chyun - Moomoo
CG Oncology, Inc. Actuals & Estimates (NASDAQ:CGON) - TradingView
CG Oncology, Inc. Actuals & Estimates (BOATS:CGON) - TradingView
CGON Forecast — Price Target — Prediction for 2027 - TradingView
CG Oncology (NASDAQ: CGON) director sells 5,000 shares, exercises options - Stock Titan
CG Oncology Inc (CGON) Institutional Confidence - TradingKey
Form 144 CG Oncology For: 24 June By Investing.com - Investing.com Nigeria
Form 144: 5,000-share exercise sale reports for CGON (CGON) - Stock Titan
CG Oncology | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
CG Oncology touts bladder cancer data, Q4 filing plans at RBC conference - MSN
CG Oncology (NASDAQ: CGON) director exercises options and sells 5,000 shares - Stock Titan
Piper Sandler Maintains CG Oncology(CGON.US) With Buy Rating, Announces Target Price $82 - Moomoo
Form 144 CG Oncology For: 22 June By Investing.com - Investing.com Australia
CGON (NASDAQ: CGON) files notice to sell 6,000 shares on 06/22/2026 - Stock Titan
CG Oncology Inc (CGON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CG Oncology Inc (CGON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CG Oncology Inc (CGON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CG Oncology Inc (CGON) Valuation: PE, PB & Fair Value Analysis - TradingKey
CG Oncology Inc (CGON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CG Oncology Inc (CGON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CG Oncology Inc (CGON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CG Oncology Inc (CGON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cg oncology director James Mulay sells $118,075 in stock By Investing.com - Investing.com India
Cg oncology director James Mulay sells $118,075 in stock - Investing.com UK
Cg Oncology Inc Stock (CGON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cg Oncology Inc Stock (CGON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Liu Brian Guan-Chyun | Director |
Jun 25 '26 |
Buy |
66.87 |
371,085 |
24,814,454 |
1,886,236 |
| POST LEONARD E | Director |
Jun 24 '26 |
Option Exercise |
0.60 |
5,000 |
3,000 |
5,000 |
| POST LEONARD E | Director |
Jun 24 '26 |
Sale |
70.00 |
5,000 |
350,000 |
0 |
1.18%
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):